Literature DB >> 23085435

Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.

Masanobu Tsubaki1, Tatsuki Itoh, Takao Satou, Motohiro Imano, Makiko Komai, Naoki Ogawa, Junji Mukai, Shozo Nishida.   

Abstract

Nitrogen-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small G-proteins. However, the details of the apoptosis-inducing mechanism remain obscure. The present study showed that the induction of apoptosis by N-BPs in hematopoietic tumor cells is mediated by mitochondrial apoptotic signaling pathways, which are activated by the suppression of geranylgeranyl pyrophosphate (GGPP) biosynthesis. Furthermore, N-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression. The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways. The accumulation of N-BPs in bones suggests that they may act more effectively on tumors that have spread to bones or on Ras-variable tumors. This is the first study to show that the specific molecular pathways of N-BP-induced apoptosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085435     DOI: 10.1016/j.bcp.2012.10.009

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.

Authors:  Tsutomu Nakazawa; Mitsutoshi Nakamura; Ryosuke Matsuda; Fumihiko Nishimura; Young Soo Park; Yasushi Motoyama; Yasuo Hironaka; Ichiro Nakagawa; Hiroshi Yokota; Shuichi Yamada; Kentaro Tamura; Yasuhiro Takeshima; Kouji Omoto; Yoshitaka Tanaka; Yukiteru Ouji; Masahide Yoshikawa; Takahiro Tsujimura; Hiroyuki Nakase
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

2.  Bisphosphonates and statins inhibit expression and secretion of MIP-1α via suppression of Ras/MEK/ERK/AML-1A and Ras/PI3K/Akt/AML-1A pathways.

Authors:  Masanobu Tsubaki; Tomoya Takeda; Kotaro Sakamoto; Hirotaka Shimaoka; Arisa Fujita; Tatsuki Itoh; Motohiro Imano; Kenji Mashimo; Daiichiro Fujiwara; Katsuhiko Sakaguchi; Takao Satou; Shozo Nishida
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 3.  Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation.

Authors:  Sherry S Agabiti; Yilan Liang; Andrew J Wiemer
Journal:  Mol Membr Biol       Date:  2016-08-18       Impact factor: 2.857

4.  Differential roles of the mevalonate pathway in the development and survival of mouse Purkinje cells in culture.

Authors:  Andrew Barszczyk; Hong-Shuo Sun; Yi Quan; Wenhua Zheng; Milton P Charlton; Zhong-Ping Feng
Journal:  Mol Neurobiol       Date:  2014-06-29       Impact factor: 5.590

5.  Induction of creatine kinase release from cultured osteoclasts via the pharmacological action of aminobisphosphonates.

Authors:  Makoto Tanaka; Hiroshi Mori; Ryoji Kayasuga; Kazuhito Kawabata
Journal:  Springerplus       Date:  2015-02-03

6.  The effect of alendronate on proteome of hepatocellular carcinoma cell lines.

Authors:  Amber Ilyas; Zehra Hashim; Nadia Naeem; Kanwal Haneef; Shamshad Zarina
Journal:  Int J Proteomics       Date:  2014-02-06

7.  Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation.

Authors:  Sherry S Agabiti; Jin Li; Andrew J Wiemer
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

8.  The Regulation of Matrix Metalloproteinase Expression and the Role of Discoidin Domain Receptor 1/2 Signalling in Zoledronate-treated PC3 Cells.

Authors:  Buket Reel; Ceren Gonen Korkmaz; Mehmet Zuhuri Arun; Gokce Yildirim; Deniz Ogut; Aysegul Kaymak; Serap Cilaker Micili; Bekir Ugur Ergur
Journal:  J Cancer       Date:  2015-08-28       Impact factor: 4.207

9.  Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation.

Authors:  Masanobu Tsubaki; Makiko Komai; Tatsuki Itoh; Motohiro Imano; Kotaro Sakamoto; Hirotaka Shimaoka; Tomoya Takeda; Naoki Ogawa; Kenji Mashimo; Daiichiro Fujiwara; Junji Mukai; Katsuhiko Sakaguchi; Takao Satou; Shozo Nishida
Journal:  J Biomed Sci       Date:  2014-02-03       Impact factor: 8.410

10.  The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb.

Authors:  Dominika Rittler; Marcell Baranyi; Eszter Molnár; Tamás Garay; István Jalsovszky; Imre Károly Varga; Luca Hegedűs; Clemens Aigner; József Tóvári; József Tímár; Balázs Hegedűs
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.